| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 09/11/2023 | 23:00 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 28/09/2023 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 26/09/2023 | 23:23 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 26/09/2023 | 23:17 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 01/08/2023 | 23:22 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 01/08/2023 | 14:42 | Edgar (US Regulatory) | Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 01/08/2023 | 01:27 | GlobeNewswire Inc. | Assertio Holdings, Inc. Closes Spectrum Pharmaceuticals Transaction | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 27/07/2023 | 23:21 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 27/07/2023 | 22:01 | GlobeNewswire Inc. | Assertio Holdings, Inc. Announces Favorable Vote on Proposed Acquisition of Spectrum Pharmaceuticals | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 20/07/2023 | 14:17 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 20/07/2023 | 13:00 | Business Wire | Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “FOR” Proposed Transaction with Assertio Holdings, Inc. | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 23/06/2023 | 22:32 | Edgar (US Regulatory) | Report of Proposed Sale of Securities (144) | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 15/06/2023 | 22:29 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquisition (definitive) (defm14a) | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 31/05/2023 | 01:36 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 17/05/2023 | 13:09 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 17/05/2023 | 13:00 | Business Wire | Spectrum Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 11/05/2023 | 22:04 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 09/05/2023 | 13:17 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 09/05/2023 | 13:00 | Business Wire | Spectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 01/05/2023 | 22:42 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 26/04/2023 | 12:01 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 25/04/2023 | 12:00 | GlobeNewswire Inc. | Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in All Stock and CVR Transaction | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 31/03/2023 | 22:47 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 22/03/2023 | 13:00 | Business Wire | Spectrum Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Corporate Update | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 17/03/2023 | 12:00 | Business Wire | Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 14/02/2023 | 19:31 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 13/02/2023 | 23:32 | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 08/02/2023 | 13:00 | Business Wire | Spectrum Pharmaceuticals Receives Permanent J-Code for ROLVEDON™ (eflapegrastim-xnst) Injection (J1449) from U.S. Centers for Medicare & Medicaid Services | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 03/02/2023 | 11:45 | PR Newswire (US) | SPPI SHAREHOLDER ALERT: Jakubowitz Law Reminds Spectrum Shareholders of a Lead Plaintiff Deadline of February 3, 2023 | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |
| 01/02/2023 | 11:45 | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 3, 2023 - (NASDAQ: SPPI) | NASDAQ:SPPI | Spectrum Pharmaceuticals Inc |